5IZ6

Protein-protein interaction


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.15 Å
  • R-Value Free: 0.206 
  • R-Value Work: 0.163 
  • R-Value Observed: 0.165 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration.

Jiang, H.Deng, R.Yang, X.Shang, J.Lu, S.Zhao, Y.Song, K.Liu, X.Zhang, Q.Chen, Y.Chinn, Y.E.Wu, G.Li, J.Chen, G.Yu, J.Zhang, J.

(2017) Nat Chem Biol 13: 994-1001

  • DOI: 10.1038/nchembio.2442
  • Primary Citation of Related Structures:  
    5B6G, 5IZA, 5IZ6, 5IZ9, 5IZ8

  • PubMed Abstract: 
  • The binding of adenomatous polyposis coli (APC) to its receptor Asef relieves the negative intramolecular regulation of Asef and leads to aberrant cell migration in human colorectal cancer. Because of its crucial role in metastatic dissemination, the ...

    The binding of adenomatous polyposis coli (APC) to its receptor Asef relieves the negative intramolecular regulation of Asef and leads to aberrant cell migration in human colorectal cancer. Because of its crucial role in metastatic dissemination, the interaction between APC and Asef is an attractive target for anti-colorectal-cancer therapy. We rationally designed a series of peptidomimetics that act as potent inhibitors of the APC interface. Crystal structures and biochemical and cellular assays showed that the peptidomimetics in the APC pocket inhibited the migration of colorectal cells by disrupting APC-Asef interaction. By using the peptidomimetic inhibitor as a chemical probe, we found that CDC42 was the downstream GTPase involved in APC-stimulated Asef activation in colorectal cancer cells. Our work demonstrates the feasibility of exploiting APC-Asef interaction to regulate the migration of colorectal cancer cells, and provides what to our knowledge is the first class of protein-protein interaction inhibitors available for the development of cancer therapeutics targeting APC-Asef signaling.


    Organizational Affiliation

    Medicinal Bioinformatics Center, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Adenomatous polyposis coli proteinA354Homo sapiensMutation(s): 0 
Gene Names: APCDP2.5
Find proteins for P25054 (Homo sapiens)
Explore P25054 
Go to UniProtKB:  P25054
NIH Common Fund Data Resources
PHAROS  P25054
Protein Feature View
Expand
  • Reference Sequence
  • Find similar proteins by:  Sequence   |   Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
PHQ-ALA-GLY-GLU-ALA-LEU-TYR-GLU-NH2B9Homo sapiensMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
PEG
Query on PEG

Download CCD File 
A
DI(HYDROXYETHYL)ETHER
C4 H10 O3
MTHSVFCYNBDYFN-UHFFFAOYSA-N
 Ligand Interaction
SO4
Query on SO4

Download CCD File 
A
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.15 Å
  • R-Value Free: 0.206 
  • R-Value Work: 0.163 
  • R-Value Observed: 0.165 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 51.396α = 90
b = 63.215β = 95.61
c = 52.768γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-3000data reduction
HKL-3000data processing
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Natural Science Foundation of ChinaChina81322046, 81473137, 81302698

Revision History 

  • Version 1.0: 2017-07-05
    Type: Initial release
  • Version 1.1: 2019-01-23
    Changes: Data collection, Database references